Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tourette's syndrome
Tourette's syndrome
Lundbeck strikes $250M Abide buyout, bagging Tourette's drug
Fierce Biotech
Mon, 05/6/19 - 10:50 am
Lundbeck
Abide Therapeutics
M&A
Tourette's syndrome
Neurocrine down on Phase IIb Tourette syndrome miss
BioCentury
Wed, 12/12/18 - 06:38 pm
Neurocrine
Tourette's syndrome
valbenazine
Israel's Therapix gets positive Tourette's drug trial results
Reuters
Tue, 04/10/18 - 09:49 am
Therapix Biosciences
clinical trials
Tourette's syndrome
cannabinoids
Hard charging Neurocrine hit with a sudden setback as Tourette study flops
Endpoints
Wed, 05/24/17 - 10:38 am
Neurocrine
Tourette's syndrome
Ingrezza
Neurocrine's Tourette drug misses mark in mid-stage trial
BioPharma Dive
Fri, 01/20/17 - 09:42 am
Neurocrine
Tourette's syndrome
clinical trials
Ingrezza
Trying brain pacemakers to zap psychiatric disease
Tue, 02/22/11 - 10:27 am
psychiatric disease
brain pacemakers
deep brain stimulation
Tourette's syndrome